GlassScriptPhysician profile
Eli K Michaels
NPI 1396850855
$6,333.02
in general payments reported to CMS, 2019-2025
47 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $491 · 2021: $1,024 · 2022: $1,013 · 2023: $761 · 2024: $841 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,836 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,836.12 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $892.15 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $416.74 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $374.31 | 2020-2025 | Lynparza |
| Sumitomo Pharma America, INC. | $372.08 | 2023-2025 | Gemtesa |
| Pfizer INC. | $366.16 | 2019-2025 | |
| Abbvie INC. | $343.91 | 2019-2025 | |
| Antares Pharma, INC. | $252.48 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $236.58 | 2019-2025 | Speedicath |
| Merck Sharp & Dohme LLC | $231.85 | 2020-2025 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $231.52 | 2019-2025 | Erleada |
| Procept Biorobotics Corporation | $227.39 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $224.57 | 2019-2025 | Provenge |
| Travere Therapeutics, INC. | $178.86 | 2019-2022 | |
| Blue Earth Diagnostics | $163.55 | 2019-2025 | Posluma |
| Angiodynamics, INC. | $147.18 | 2021-2025 | Nanoknife |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eli Michaels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.